---
schema_version: "secwatch.filing_event.v1"
accession: "0001683168-22-002838"
form_type: "8-K"
ticker: "ODYY"
cik: "0001626644"
company_name: "Odyssey Health, Inc."
filed_at: "2022-04-20T23:59:59+00:00"
generated_at: "2026-06-26T06:12:03.267484+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Odyssey Health adds Vice Admiral (r) Timothy Szymanski to Military Advisory Board

## Summary
- Vice Admiral (r) Szymanski served 36 years as Navy SEAL, most recently Deputy Commander USSOCOM.
- He established cognitive baseline policy for Special Operations and created brain health initiatives.
- Odyssey's concussion drug candidate PRV-002 is currently in Phase 1 clinical trial.
- Up to 3.8 million concussions occur annually in the U.S., with 30-50% unreported.

## SEC filing metadata
- accession: 0001683168-22-002838
- form_type: 8-K
- ticker: ODYY
- cik: 0001626644
- company_name: Odyssey Health, Inc.
- filed_at: 2022-04-20T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 8.01, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1626644/000168316822002838/0001683168-22-002838-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1626644/000168316822002838/ody_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001683168-22-002838
- JSON: https://secwatch.observer/filing/0001683168-22-002838.json
- Plain text: https://secwatch.observer/filing/0001683168-22-002838.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.